Programs immune cells which harness engineered regulatory T‑cell therapies to target tumors safely and precisely.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
CoRegen is a biopharmaceutical company leveraging its proprietary gene regulatory platform to engineer immune cells for novel cancer therapies. It programs regulatory T cells by targeting master gene regulators, enabling them to infiltrate tumors and activate immune responses while mitigating toxicity. The platform advances new adoptive cell therapies for challenging cancers by combining gene editing with immune system modulation.
CoRegen Funding
Sign up to gain insights into CoRegen funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | May 08, 2025 | 63M | ||
| Series A | Feb 03, 2025 | 8M | ||
| Series A | Feb 03, 2025 | 3M | ||
| Series A | Jan 19, 2025 | 21M | ||
| Series A | Feb 08, 2024 | 15M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
CoRegen Management Team
CoRegen Valuations & Financials
View real-time NPM data on CoRegen stock including daily CoRegen stock price estimates, valuation history, and historical share price information. Access CoRegen financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track CoRegen pricing across six independent market signals. Looking for private company due diligence data sources on CoRegen? Get in touch to learn more.
Similar Companies
like CoRegen
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
FAQ
We have answers
CoRegen stock does not trade on public stock exchanges. CoRegen stock is considered a private security and you need to be an accredited investor to trade shares. To invest in CoRegen stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
CoRegen Stock does not trade on public stock exchanges. In order to sell CoRegen shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
CoRegen does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view CoRegen share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for CoRegen stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell CoRegen stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in CoRegen stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
CoRegen is a private company and has not had an IPO. There is currently no CoRegen IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to CoRegen IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
